Skip to Main Content

Try STAT+ TODAY

pharmaceuticals

Most Read

Health Tech Katie Palmer

‘This is pharma’s dream’: How drugmakers are turning telehealth into a marketing gold mine

Pharmalot Ed Silverman

J&J wins a partial appeal against the U.K.’s cost-effectiveness watchdog over ‘unfair’ review

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Even before Covid-19, remote trials saved money. Will pharma now rely on them more than ever?

First Opinion Joan Bregstein

Paxlovid rebound happens, though why and to whom are still a mystery

A STAT Investigation Casey Ross

Internal documents show privacy lapses at a data powerhouse that holds health records and consumer information on millions of Americans

Health Elissa Welle

FDA approves first at-home therapy for skin repigmentation in vitiligo patients

First Opinion Paul Fenyves

Does Paxlovid help people who have been vaccinated against Covid-19? Show us the data!

All Coverage

Pharmalot Ed Silverman

Inflation caused another big drop in net drug prices, analysis finds

Pharmalot Ed Silverman

Pfizer accused of running a fellowship program that discriminates on racial grounds

advertisement

Pharmalot Ed Silverman

Pharmalittle: CRISPR-based drug shows promise in preliminary study; FDA user fee program prompts fresh worries over conflicts

Pharmalot Ed Silverman

Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug

Pharmalot Ed Silverman

Swiss authorities raid Novartis offices seeking info on patents used to block rivals

Health Tech Katie Palmer

Tell us about your experience with telehealth linked to pharma companies

First Opinion Podcast Patrick Skerrett

Listen: A doctor with ALS laments the slow pace for drug approval

Pharmalot Ed Silverman

Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks

Pharmalot Jason Mast

Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics

Pharmalot Jonathan Wosen

Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics

Pharmalot Jonathan Wosen

Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year

Pharma Tara Bannow

In a new lawsuit, pharma-backed patient groups fight federal rule around copay coupons

Pharmalot Allison DeAngelis

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

First Opinion Lung-I Cheng

Five years after Kymriah: Ensuring the next cell and gene therapies reach patients

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Centene agrees to pay $33 million to resolve another state probe into its pharmacy benefits business

Pharmalot Ed Silverman

Pharmalittle: House report shows Trump sought to pressure FDA on Covid response; Pfizer Covid pill provides little benefit to younger adults

Biotech Isabella Cueto

Faster drug approval route sparks investment in rare kidney disease treatments

Pharmalot Ed Silverman

FDA scolds Sun Pharma for allegedly backdating documents and fudging records for collecting drug samples

Biotech Jason Mast

Merck, a loser in the Covid vaccine race, reinvests in mRNA through a Cambridge startup

Pharmalot Ed Silverman

Sales from controversial drug discount program rose to $44 billion last year

Politics Rachel Cohrs

Cancer patient who devoted six years to drug pricing reform isn’t done yet

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Exclusive Ed Silverman

Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy

Adam's Take Adam Feuerstein

With Pfizer deal, Global Blood CEO sees opportunity to reach sickle cell patients globally